New mRNA HIV vaccine trial aims to train immune system to fight virus
NCT ID NCT06557785
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 21 times
Summary
This early-stage study tests two experimental mRNA vaccines designed to teach the body to make powerful antibodies that can neutralize many strains of HIV. The trial involves 53 healthy adults without HIV to check safety and immune responses. If successful, this approach could lead to a preventive HIV vaccine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center (Site ID: 32077)
Boston, Massachusetts, 02215, United States
-
Columbia P&S (Site ID: 30329)
New York, New York, 10032, United States
-
New York Blood Center (Site ID: 31801)
New York, New York, 10065, United States
-
Penn Prevention (Site ID: 30310)
Philadelphia, Pennsylvania, 19104, United States
-
Seattle Vaccine and Prevention (Site ID: 30331)
Seattle, Washington, 98104, United States
-
University of Pittsburgh (Site ID: 1001)
Pittsburgh, Pennsylvania, 15213, United States
-
Vaccine Trial Centre, Mahidol University CRS (Site ID: 32021)
Bangkok, Ratchathewi, 10400, Thailand
Conditions
Explore the condition pages connected to this study.